PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 223 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $275,000 | -12.7% | 11,498 | -2.3% | 0.00% | 0.0% |
| Q3 2019 | $315,000 | -21.8% | 11,768 | -21.0% | 0.00% | -33.3% |
| Q2 2019 | $403,000 | +41.4% | 14,900 | +81.9% | 0.00% | +50.0% |
| Q1 2019 | $285,000 | +90.0% | 8,190 | +7.0% | 0.00% | +100.0% |
| Q4 2018 | $150,000 | -30.6% | 7,652 | -5.6% | 0.00% | -50.0% |
| Q3 2018 | $216,000 | -11.8% | 8,110 | +7.8% | 0.00% | 0.0% |
| Q2 2018 | $245,000 | 0.0% | 7,524 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $245,000 | -31.2% | 7,524 | +2.9% | 0.00% | -33.3% |
| Q4 2017 | $356,000 | -6.1% | 7,314 | +4.3% | 0.00% | -25.0% |
| Q3 2017 | $379,000 | +3.0% | 7,014 | +7.0% | 0.00% | 0.0% |
| Q2 2017 | $368,000 | +43.8% | 6,554 | +0.2% | 0.00% | +33.3% |
| Q1 2017 | $256,000 | +59.0% | 6,543 | -8.5% | 0.00% | +50.0% |
| Q4 2016 | $161,000 | -13.9% | 7,148 | -13.3% | 0.00% | -33.3% |
| Q3 2016 | $187,000 | -2.1% | 8,245 | +1.8% | 0.00% | 0.0% |
| Q2 2016 | $191,000 | +30.8% | 8,101 | +13.2% | 0.00% | 0.0% |
| Q1 2016 | $146,000 | -60.8% | 7,157 | -1.0% | 0.00% | -57.1% |
| Q4 2015 | $372,000 | +39.3% | 7,232 | +15.3% | 0.01% | +16.7% |
| Q3 2015 | $267,000 | +73.4% | 6,273 | +84.6% | 0.01% | +100.0% |
| Q2 2015 | $154,000 | +97.4% | 3,398 | +65.9% | 0.00% | +200.0% |
| Q1 2015 | $78,000 | +36.8% | 2,048 | +2.4% | 0.00% | 0.0% |
| Q4 2014 | $57,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |